Alison Falb
Partner
Alison Falb brings a unique and timely perspective on health care transformation across agencies to Coral Health Advisors. At the FDA, she worked on regulatory policies for biosimilars and generic drugs, while at CMS, she helped implement MACRA and shape alternative payment models addressing specialty care, episode-based payments, and drug pricing. Alison holds a JD from Fordham University School of Law and a BA from Brown University.
More from Alison Falb
-
Season 1 | Episode 16 | PFS 2026 & ASM: What ACOs and Specialists Need to Know
In this episode, Melissa Cohen is joined by Coral Health Advisors’ Alison Falb and Joy Chen to break down key updates for ACOs in the CY 2026 Medicare Physician Fee Schedule Proposed Rule and explore the new mandatory Ambulatory Specialty Model.
-
Trump Executive Order Directing Development of New Drug Pricing Model
President Trump issued an Executive Order on April 15, 2025 focused on lowering high drug prices for Americans, reinforcing a goal set in his previous administration.